Wearable maker Oura announced on November 10, 2026 that it will acquire Counsel Health, an AI-native primary care startup, for $625 million. Counsel’s chat-based medical AI and licensed physicians, already integrated into the Oura app since June 2026, will now be fully absorbed into Oura’s business.
What the deal covers
According to TechCrunch’s report, citing Oura’s own press release distributed via Business Wire, Oura is acquiring Counsel Health outright for $625 million. The release does not specify whether the deal is structured as cash, stock, or a mix, and it is expected to close before the end of 2027.
Counsel’s roughly 70 employees, including chief executive Muthu Alagappan, will join Oura. Alagappan will take the title of chief clinical AI officer at Oura. Counsel’s enterprise partnerships outside Oura will continue, with the stated goal of extending its care model beyond Oura’s own membership base.
Why Oura is buying now
The acquisition follows Oura’s decision to indefinitely postpone an initial public offering that had been expected to raise up to $2.2 billion, which the company attributed to uncertainty in the IPO market. Oura chief executive Tom Hale said in the release, “Oura helps members understand their physiology and, with Counsel, they can take action on their health.”
Oura reported revenue of $533 million for the quarter ended September 30, 2026, up 153 percent year over year, with fiscal 2026 revenue of roughly $1.75 billion, up 92 percent. The company was last valued at $11 billion after a $900 million funding round in October 2025.
What Counsel Health brought to the table
Counsel combines a chat-based medical AI with access to licensed physicians, a model it calls AI-native primary care. The company integrated this service into the Oura app in June 2026 as a partnership, rolling out first to eligible members across 43 US states. Before the acquisition, Counsel had raised a $25 million Series A led by Andreessen Horowitz and GV, with PitchBook estimating its total funding at $36 million.
Oura has said that data from the integration will not be sold, a commitment the company made when the Counsel partnership first launched in June 2026. The medical AI chat function is not meant to replace emergency care, and the companies have said it will not cover every aspect of a member’s health needs.
Wearable makers are moving into clinical care
Oura built its business on a ring that tracks sleep, readiness, and recovery metrics, selling data and insight without directly offering treatment. Buying Counsel Health moves Oura from measurement into actual care delivery, pairing its physiological data with a licensed clinical team and medical AI that can act on it.
The move mirrors a broader pattern among consumer health and wearable companies, which have increasingly tried to close the loop between tracking a health metric and doing something about it, rather than leaving that step to a separate doctor’s visit or app. For Oura, folding a primary care provider directly into its own product removes a step between a flagged health trend and a physician’s response.
The deal by the numbers
| Metric | Figure |
|---|---|
| Acquisition price | $625 million |
| Counsel employees joining Oura | About 70 |
| Counsel’s prior total funding (PitchBook estimate) | $36 million |
| Counsel’s Series A (a16z, GV) | $25 million |
| Oura’s Q3 2026 revenue (quarter ended Sept 30) | $533 million, up 153% YoY |
| Oura’s fiscal 2026 revenue | About $1.75 billion, up 92% |
| Oura’s last valuation (Oct 2025 round) | $11 billion |
| Oura’s shelved IPO size | Up to $2.2 billion |
Frequently asked questions
Does this change what Oura ring or app users see today?
The announcement does not detail immediate product changes. Counsel’s medical AI chat and physician access were already live inside the Oura app since June 2026 under the partnership; the acquisition brings that service fully in-house.
Is Counsel’s care free with an Oura membership?
Medical AI chat has been included with Oura Membership, while visits and treatment from Counsel’s physicians carry additional costs. The release does not say this will change after the acquisition closes.
Why didn’t Oura go public instead?
Oura put its planned IPO, which could have raised up to $2.2 billion, on indefinite hold, citing uncertain IPO market conditions, and pursued this acquisition instead.
Oura was founded in Finland in 2013 and built its reputation on the Oura Ring, a finger-worn tracker for sleep, heart rate variability, and recovery. The company has previously relied on data partnerships and subscription revenue rather than offering medical treatment directly, making the Counsel acquisition a shift in how far into healthcare Oura is willing to expand. Rivals in the wearables space, including Whoop and Fitbit, have so far stopped short of acquiring a licensed primary care provider outright.
What to watch next is whether the deal closes on schedule before the end of 2027 and whether Oura folds Counsel’s physician network into paid tiers of its membership, or keeps it as a separate add-on cost.
Leave a Reply